Tag:

Mitsubishi Tanabe

Latest Headlines

Latest Headlines

Mitsubishi Tanabe set to buy Medicago for VLP technology

July 18, 2013 | By
Life science stocks are hot, venture capitalists have renewed their interest in biotech and a host of big companies are on the hunt for startup vaccine makers with novel products and technology. Medicago is the latest developmental vaccine maker to attract a bid. 

Mitsubishi Tanabe's 2M-unit recall follows QC lapse

FiercePharma Manufacturing | January 26, 2011
A QC lapse has led Mitsubishi Tanabe Pharma to recall 2 million doses of three parenterals. The company says that for certain lots of the products, some aspects of pre-ship testing didn't make the
Related Tags

Mitsubishi Tanabe Press Releases

  • Mitsubishi Tanabe Pharma Starts Voluntary Recall of Injection Solution Products
Press Releases
  • U.S. FDA Panel Supports Medtronic, Inc. (MDT) Pacemaker
  • Atritech, Inc. Announces FDA Regulatory Update; Confirmatory Study Required for Final FDA Approval
  • FDA APPROVES FIRST OF ITS KIND, FULLY IMPLANTABLE (SURGICALLY), INVISIBLE, PROSTHETIC HEARING RESTORATION DEVICE
  • CryoLife Comments on Status of Medafor Distribution Agreement
  • FDA Statement on Boston Scientific Recall of Implantable Cardioverter Defibrillators
  • More Press Releases
Featured Jobs
  • Director, Business Solutions -Program/Project Management - 13000001GU
    Abbvie - Chicago IL United States
  • Project Manager - Regulatory Affairs
    Wockhardt -
  • Vice President, Global Medical Affairs - Melanoma Job
    Celgene Corporation - Summit NJ US
  • Clinical Data Manager
    Lexicon Pharmaceuticals -
  • Senior Director, Translational Development, Hematology / Oncology Job
    Celgene Corporation - San Francisco CA US
Sponsored Links